Graft Patency After FFR-guided Versus Angio-guided CABG (GRAFFITI) Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 206 participants.

Also called NCT01810224

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 206 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01810224
Other papers using this trial's data
  • Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting: the GRAFFITI trial EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2019-12-06 DOI, PubMed 31270037

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
Belgium, Czechia, Hungary (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01810224. Randomized; double masking; primary purpose treatment. Start 2013-03 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Graft Patency After FFR-guided Versus Angio-guided CABG (GRAFFITI) Trial
Acronym
GRAFFITI
Intervention (Procedure)
Surgical revascularization
Lead sponsor
Onze Lieve Vrouw Hospital (class: other)

Record details

Record id
cardio:ct-nct01810224
Content hash
57da612f2b53f5e5d07897730d2cc8a0c296e76915e3aeef005809c1c0cc8688